Published in J Clin Hypertens (Greenwich) on June 01, 2009
Simultaneous cardiac and renal damage in a hypertensive population. J Clin Hypertens (Greenwich) (2009) 0.75
The association between elevated cystatin C levels with myocardial infarction: a meta-analysis. Int J Clin Exp Med (2015) 0.75
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2007) 20.09
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2007) 9.43
[An invasive strategy in non-ST-segment elevation acute coronary syndromes. From large trials to the real world]. Rev Esp Cardiol (2004) 2.03
[Use of sirolimus-eluting stents in complex lesions: clinical and angiographic follow-up]. Rev Esp Cardiol (2004) 1.60
Validation of the SAMe-TT2R2 score in a nationwide population of nonvalvular atrial fibrillation patients on vitamin K antagonists. Thromb Haemost (2015) 1.49
Erectile dysfunction in high-risk hypertensive patients treated with beta-blockade agents. Cardiovasc Ther (2010) 1.48
[Emergency room risk stratification of patients with chest pain without ST segment elevation]. Rev Esp Cardiol (2003) 1.46
Impact of new criteria for anticoagulant treatment in atrial fibrillation. Rev Esp Cardiol (2011) 1.44
Low levels of high-density lipoproteins cholesterol are independently associated with acute coronary heart disease in patients hospitalized for chest pain. Rev Esp Cardiol (Engl Ed) (2011) 1.43
[Treatment of acute myocardial infarction by primary angioplasty on-site compared with treatment following interhospital transfer: short- and long-time clinical outcomes]. Rev Esp Cardiol (2007) 1.41
A practical approach with outcome for the prognostic assessment of non-ST-segment elevation chest pain and normal troponin. Am J Cardiol (2007) 1.41
[Myocardial echocardiography with intracoronary injection of contrast in post-infarction patients. Implications and comparison with angiography and magnetic resonance imaging]. Rev Esp Cardiol (2004) 1.40
[Sex differences in mortality at one-month and at one-year after an acute coronary syndrome]. Med Clin (Barc) (2004) 1.39
[Plasma concentration of big endothelin-1 and its relation with plasma NT-proBNP and ventricular function in heart failure patients]. Rev Esp Cardiol (2005) 1.38
[Impact of blood pressure control on the ankle-brachial index in hypertensive patients]. Med Clin (Barc) (2012) 1.38
Blood pressure control in hypertensive women aged 65 years or older in a primary care setting. MERICAP study. Rev Esp Cardiol (2011) 1.38
Implantation of single-lead atrioventricular permanent pacemakers guided by electroanatomic navigation without the use of fluoroscopy. Europace (2008) 1.30
Characteristics and outcome of acute myocardial infarction in young patients. The PRIAMHO II study. Cardiology (2006) 1.13
Differential prognostic effect of systolic blood pressure on mortality according to left-ventricular function in patients with acute heart failure. Eur J Heart Fail (2010) 1.12
New risk score for patients with acute chest pain, non-ST-segment deviation, and normal troponin concentrations: a comparison with the TIMI risk score. J Am Coll Cardiol (2005) 1.10
Differential mortality association of loop diuretic dosage according to blood urea nitrogen and carbohydrate antigen 125 following a hospitalization for acute heart failure. Eur J Heart Fail (2012) 1.01
Usefulness of an abnormal ankle-brachial index for detecting multivessel coronary disease in patients with acute coronary syndrome. Rev Esp Cardiol (2010) 0.95
Usefulness of early exercise testing and clinical risk score for prognostic evaluation in chest pain units without preexisting evidence of myocardial ischemia. Am J Cardiol (2006) 0.92
"Do GRACE (Global Registry of Acute Coronary events) risk scores still maintain their performance for predicting mortality in the era of contemporary management of acute coronary syndromes?". Am Heart J (2010) 0.92
Obese subjects with heart failure have lower N-terminal pro-brain natriuretic peptide plasma levels irrespective of aetiology. Eur J Heart Fail (2005) 0.91
Carbohydrate antigen 125: an emerging prognostic risk factor in acute heart failure? Heart (2006) 0.90
[ESH/ESC 2007 Guidelines for the management of arterial hypertension]. Rev Esp Cardiol (2007) 0.90
[Prognostic value of Charlson comorbidity index at 30 days and 1 year after acute myocardial infarction]. Rev Esp Cardiol (2004) 0.90
Consensus document for the detection and management of chronic kidney disease. Nefrologia (2014) 0.88
Improvement in risk stratification with the combination of the tumour marker antigen carbohydrate 125 and brain natriuretic peptide in patients with acute heart failure. Eur Heart J (2010) 0.87
Prognostic value of low ankle-brachial index in patients with hypertension and acute coronary syndromes. J Hypertens (2009) 0.87
[Acute myocardial infarction in patients under 45 years]. Rev Esp Cardiol (2002) 0.87
Obese and nonobese patients with essential hypertension show similar N-terminal proBNP plasma levels. Am J Hypertens (2008) 0.86
Variability of NT-proBNP plasma and urine levels in patients with stable heart failure: a 2-year follow-up study. Heart (2007) 0.86
Low lymphocyte count in acute phase of ST-segment elevation myocardial infarction predicts long-term recurrent myocardial infarction. Coron Artery Dis (2010) 0.86
Usefulness of a comprehensive cardiovascular magnetic resonance imaging assessment for predicting recovery of left ventricular wall motion in the setting of myocardial stunning. J Am Coll Cardiol (2005) 0.86
Prognostic usefulness of white blood cell count on admission and one-year outcome in patients with non-ST-segment elevation acute chest pain. Am J Cardiol (2006) 0.86
Complete regression of cardiac non-Hodgkin lymphoma. Int J Cardiol (2006) 0.84
Combination of ankle brachial index and diabetes mellitus to predict cardiovascular events and mortality after an acute coronary syndrome. Int J Cardiol (2010) 0.84
Impact of clinical and subclinical peripheral arterial disease in mid-term prognosis of patients with acute coronary syndrome. Am J Cardiol (2009) 0.84
Inflammation and apoptosis in hypertension. Relevance of the extent of target organ damage. Rev Esp Cardiol (Engl Ed) (2012) 0.83
Differences in medical treatment of chronic coronary heart disease patients according to medical specialities. Cardiovasc Ther (2009) 0.83
Burden of systemic hypertension in patients admitted to cardiology hospitalization units. Am J Cardiol (2011) 0.83
Diagnostic and prognostic value of urine NT-proBNP levels in heart failure patients. Eur J Heart Fail (2006) 0.83
Variability of NT-proBNP and its relationship with inflammatory status in patients with stable essential hypertension: a 2-year follow-up study. PLoS One (2012) 0.83
Antigen carbohydrate 125 and brain natriuretic peptide serial measurements for risk stratification following an episode of acute heart failure. Int J Cardiol (2011) 0.81
Inflammatory activation and left ventricular mass in essential hypertension. Am J Hypertens (2009) 0.81
[Reinfarction as a complication of acute myocardial infarction. PRIMVAC Registry data]. Rev Esp Cardiol (2005) 0.81
[Factors associated with uncontrolled hypertension in patients with and without cardiovascular disease]. Rev Esp Cardiol (2011) 0.81
Prognostic significance of heart rate in hospitalized patients presenting with myocardial infarction. World J Cardiol (2012) 0.81
Risk stratification in non-ST elevation acute coronary syndromes: predictive power of troponin I, C-reactive protein, fibrinogen and homocysteine. Int J Cardiol (2005) 0.80
Sex differences in the hypertensive population with chronic ischemic heart disease. J Clin Hypertens (Greenwich) (2008) 0.80
Prognostic differences between routine invasive and conservative strategies for the management of high-risk, non-ST segment acute coronary syndromes: Experience from two consecutive periods in a single center. Eur J Intern Med (2007) 0.80
Clinical course of acute myocardial infarction in the hypertensive patient in Eastern Spain: the PRIMVAC registry. Heart Lung (2006) 0.80
Usefulness of concomitant myoglobin and troponin elevation as a biochemical marker of mortality in non-ST-segment elevation acute coronary syndromes. Am J Cardiol (2003) 0.80
MMP-2 and sTNF-R1 Variability in Patients with Essential Hypertension: 1-Year Follow-Up Study. ISRN Cardiol (2012) 0.80
Soluble TNF-alpha and interleukin-6 receptors in the urine of heart failure patients. Their clinical value and relationship with plasma levels. Eur J Heart Fail (2004) 0.80
[Prognostic value of serum creatinine in non-ST-elevation acute coronary syndrome]. Rev Esp Cardiol (2006) 0.80
Anticoagulation prescription in atrial fibrillation. Expert Opin Pharmacother (2011) 0.79
Prevalence of atrial fibrillation and use of antithrombotics in hypertensive patients aged >or=65 years. The FAPRES trial. Rev Esp Cardiol (2010) 0.79
[Magnitude and characteristics of residual lipid risk in patients with a history of coronary revascularization: the ICP-bypass study]. Rev Esp Cardiol (2011) 0.79
Impact of cardiovascular risk factors and inflammatory status on urinary 8-OHdG in essential hypertension. Am J Hypertens (2011) 0.79
High heart rate: more than a risk factor. Lessons from a clinical practice survey. Int J Cardiol (2008) 0.79
Trends in clinical profile and medical treatments of atrial fibrillation patients over the last 10 years. Rev Port Cardiol (2013) 0.79
Multimarker risk strategy for predicting 1-month and 1-year major events in non-ST-elevation acute coronary syndromes. Am Heart J (2005) 0.79
Plasma aldosterone and glomerular filtration in hypertensive patients with preserved renal function. Rev Esp Cardiol (2010) 0.79
[Prognostic value of white blood cell count in acute myocardial infarction: long-term mortality]. Rev Esp Cardiol (2005) 0.79
Prevalencia de fibrilación auricular y uso de fármacos antitrombóticos en el paciente hipertenso ≥ 65 años. El registro FAPRES. Rev Esp Cardiol (2010) 0.78
Erectile dysfunction may improve by blood pressure control in patients with high-risk hypertension. Postgrad Med (2010) 0.78
[NT-proBNP levels and hypertension. Their importance in the diagnosis of heart failure]. Rev Esp Cardiol (2004) 0.78
[Interleukin-4 and cardiac fibrosis in patients with heart failure]. Rev Esp Cardiol (2007) 0.78
Left ventricular cavity area reflects N-terminal pro-brain natriuretic peptide plasma levels in heart failure. Eur J Echocardiogr (2005) 0.78
Prevalence of carotid stenosis and silent myocardial ischemia in asymptomatic subjects with a low ankle-brachial index. J Vasc Surg (2008) 0.78
[Influence of antecedent of hypertension in patients with acute coronary syndrome without ST elevation]. Med Clin (Barc) (2006) 0.77
Gender differences related to the presence of atrial fibrillation in older hypertensive patients. World J Cardiol (2013) 0.77
Role of dihydropyridinic calcium channel blockers in the management of hypertension. Expert Rev Cardiovasc Ther (2013) 0.77
[Prevalence of primary aldosteronism in hypertensive patients and its effect on the heart]. Rev Esp Cardiol (2008) 0.77
Pathological ankle-brachial index is equivalent of advanced age in acute coronary syndromes. Eur J Clin Invest (2011) 0.77
[Relationship between myocardial modelling and diastolic function in patients with essential hypertension]. Med Clin (Barc) (2011) 0.77